Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

BACKGROUND: Antacid treatments decrease the serum concentrations of first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), although it is unknown whether antacids affect clinical outcomes. As cerebrospinal fluid concentrations of TKIs are much lower than serum co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Mu, Lai, Chien-Hao, Chang, Huang-Chih, Chao, Tung-Ying, Tseng, Chia-Cheng, Fang, Wen-Feng, Wang, Chin-Chou, Chung, Yu-Hsiu, Wang, Yi-Hsi, Su, Mao-Chang, Liu, Shih-Feng, Huang, Kuo-Tung, Chen, Hung-Chen, Chang, Ya-Chun, Lin, Meng-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760710/
https://www.ncbi.nlm.nih.gov/pubmed/26894507
http://dx.doi.org/10.1371/journal.pone.0149722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760710/
https://www.ncbi.nlm.nih.gov/pubmed/26894507
http://dx.doi.org/10.1371/journal.pone.0149722

Ejemplares similares